Developer docs
API playgroundTry for free, no card

Search company profiles

Calier

Full company profile

uuid000dqub

Namestring
Calier
Legal namestring
Laboratorios Calier S.A.
Websiteurl
calier.com
Company typeenum
Private
Founded yearint
1968
Descriptiontext

Calier (legal entity Laboratorios Calier S.A.) is a Barcelona-headquartered veterinary pharmaceuticals and biologicals manufacturer founded in 1968 and operating as a subsidiary of the Spanish diversified group Grupo Indukern. The company develops, manufactures, and markets more than 250 products spanning five species verticals: companion animals (dogs, cats, horses, ornamental birds), poultry, swine, ruminants, and beekeeping. Its product portfolio includes biological vaccines, antibiotics, anti-inflammatory drugs, antiparasitics, disinfectants, nutritional supplements, sedatives, and custom autovaccines. The flagship biological franchise centers on Salmonella control in poultry, anchored by Primun Salmonella E, a freeze-dried live attenuated Salmonella Enteritidis vaccine carrying unique antibiotic-resistance markers that enable DIVA differentiation from field strains, and the first live vaccine authorized for use during the laying period by European Medicines Agencies in May 2021. A complementary inactivated bivalent vaccine (Salmonelbac Hidrosa) supports a mixed live-plus-inactivated vaccination strategy.

The company operates four owned production plants in Spain (Les Franqueses del Vallès headquarters plus a biological plant in León), Colombia (Cali), Morocco (Salé), and Uruguay (Montevideo), and distributes through 12 wholly-owned subsidiaries plus third-party distributors to veterinary professionals, farms, and animal production facilities in more than 80 countries across Europe, Latin America, North America, and Africa. Go-to-market is enterprise field sales with species-specialized Technical Services teams advising on-farm solutions, supplemented by the CECADI diagnostic center (PCR-based water and tissue analysis) and the WEVAP digital platform launched in 2022 for auditing poultry vaccination programs via biosafety scoring, preparation checks, application monitoring, and post-vaccination evaluation. The company monetizes primarily through one-time product sales of vaccines and pharmaceuticals, with added-value services layered around technical advice, custom autovaccines, and digital diagnostics.

Revenue is not consolidated publicly; the disclosed Venezuela subsidiary reported 67M EUR in 2022 with 340+ employees, while global headcount figures are inconsistent across sources (firmographics estimate 101-250 globally versus Venezuela alone exceeding 340), suggesting Calier is a mid-tier multinational animal health player with no external venture capital or public market exposure, owned within the Indukern corporate group.

Short descriptiontext

Calier is a Barcelona-based veterinary pharmaceuticals and biologicals manufacturer, founded 1968, producing 250+ vaccines, antiparasitics, anti-inflammatories, and nutritional supplements for companion animals, poultry, swine, ruminants, and beekeeping across 80+ countries through 12 subsidiaries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBarcelona, Spain
HQ citystring
Barcelona
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices13 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary pharmaceuticals, animal biologicals, livestock vaccines, veterinary medicines, animal health products
Industry4 codes
1Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO)
CodeHLAMAKAIPrimaryYes
2Livestock & Production Animal Therapeutics (Rx)
CodeHLAMAEABPrimaryNo
3Veterinary Vaccine & Biologics Distributors
CodeHLAMAIACPrimaryNo
4Reference Laboratory Testing (Clinical Pathology & Chemistry)
CodeHLAMADAAPrimaryNo
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code3 codes
  • Pharmaceutical Preparations2834
  • Biological Products, (No Disgnostic Substances)2836
  • Services-Medical Laboratories8071
Product category
Veterinary Pharmaceuticals
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Veterinary Pharmaceutical Products
TypeOne Time License
Description

Sale of pharmacological and biological products including vaccines, antibiotics, anti-inflammatory drugs, antiparasitics, disinfectants, nutritional supplements, and sedatives for companion animals and production animals (poultry, swine, ruminants, bees).

calier.com
2Biological Products
TypeOne Time License
Description

Manufacturing and sale of biological products including live and inactivated vaccines for avian salmonellosis and other animal diseases. Production plants in Spain, Colombia, Morocco, and Uruguay.

calier.com
3Technical Services
TypeProfessional Services
Description

Added-value services including technical advice, farm auditing tools (WEVAP), and specialized technical support by species to help professionals maximize farm performance.

calier.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 9 records shown
1Primun Salmonella E
Description

Live attenuated Salmonella Enteritidis vaccine for poultry, first authorized for use during laying period

calier.com
+8 more records
Core offering1 text field

Laboratorios Calier S.A. is a veterinary pharmaceutical laboratory founded in 1968 in Barcelona, Spain, that develops, manufactures, and distributes pharmaceutical and biological products for animal health, including vaccines and medicinal specialties for livestock and companion animals. The company operates four production plants (in Spain, Colombia, Morocco, and Uruguay), supports 12 subsidiaries, and markets more than 250 products in over 80 countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Primun Salmonella E demonstrated protection up to 95 weeks of life in layers
+4 more records
Product overview1 text field

Calier (Laboratorios Calier S.A.) is a veterinary pharmaceuticals company with over 55 years of experience offering a portfolio of more than 250 products across five animal segments: companion animals, poultry, swine, ruminants, and beekeeping. The portfolio includes pharmacological and biological products such as vaccines (Primun Salmonella E, Primun Salmonella T, Salmonelbac Hidrosa, Fixr PRRS Inac), antiparasitics (Dynacan, Merlin), anti-inflammatories (Adocam), nutritional supplements (ComPet line), and autovaccines. Services include CECADI diagnostic center and WEVAP digital vaccination auditing tool. Products are marketed in over 80 countries through 12 subsidiaries with manufacturing plants in Spain, Colombia, Morocco, and Uruguay.

Product and service2 records
1Primun Salmonella E
CategoryVeterinary Biologicals / Vaccines
Description

Salmonella vaccine for poultry, part of Calier's range of biological products aimed at preventing salmonellosis in livestock production.

2WEVAP
CategoryVeterinary Pharmaceuticals
Description

Veterinary pharmaceutical/biological product contributing to Calier's portfolio of more than 250 animal health products sold worldwide.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
1Fundación Amigos de las Abejas (Friends of Bees Foundation)
Strategic tierMinorTypeOthers
Description

Charitable partnership as part of the 'Zumbados por las Abejas' project. Calier donates 3€ per photograph received in their Beekeeping Photo Contest to support awareness programs about pollinating insects and ecosystem conservation.

calier.com
2Sierras Andaluzas
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sector partnership for beekeeping awareness and promotion of technical knowledge and local honey consumption in Andalusia, Spain.

calier.com
3La Tarragonina
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Sector partnership for beekeeping sector promotion and technical knowledge sharing in the Tarragona region.

calier.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Educational content collaboration to create digital educational materials about bees and beekeeping for schools across Spain as part of the 'Zumbados por las Abejas' project.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration on educational materials and workshops in schools about the importance of beekeeping and ecosystem balance.

Strategic tierMinorTypeOthers
Description

Cloud-based productivity and collaboration tools provider located outside the EU but compliant with GDPR regulations.

Strategic tierMinorTypeOthers
Description

Customer relationship management platform provider located outside the EU but compliant with GDPR regulations.

8External Sample Collection Companies
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Partnership with external companies specializing in sample collection and water quality testing in Spain to provide comprehensive WEVAP vaccination audit services.

calier.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partnership with INTA Argentina led by Dr. Pablo Chacana for conducting vaccine efficacy challenge trials using Salmonella Enteritidis strains, in coordination with SENASA (National Agricultural Health and Quality Department).

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Independent French veterinary pharmaceutical company with portfolio of pharmaceuticals, parasiticides, and nutrition products for companion and production animals. Similar size, private-listed mid-cap profile, and therapeutic overlap.

TypeBroad incumbent
Description

Large global animal health company spanning companion animal, livestock, and poultry therapeutics and vaccines. Broad incumbent competitor across all of Calier's species segments.

TypeDirect peer
Description

UK-based specialty veterinary pharmaceuticals company acquired by EQT, with strong portfolio in companion animal endocrinology, dermatology, and anti-infectives. Comparable on mid-cap specialty pharma positioning though more companion-animal weighted.

TypeBroad incumbent
Description

Global animal health division of Boehringer Ingelheim, with major positions in poultry and swine vaccines including PRRS. Direct competitor in Calier's swine PRRS vaccine franchise (Fixr PRRS Inac).

TypeDirect peer
Description

Independent French animal health company offering vaccines, pharmaceuticals, and diagnostics across companion and production animals. Similar mid-cap profile, broad species portfolio, and direct overlap in antiparasitics and biologicals.

TypeBroad incumbent
Description

World's largest pure-play animal health company with the broadest portfolio across species, therapeutics, vaccines, diagnostics, and digital. Represents the dominant incumbent Calier competes against across multiple species segments.

TypeEmerging player
Description

US-based animal health company specializing in wound care, dermatology, and nutritional supplements for companion and production animals. Niche overlap in companion animal supplements (ComPet line category).

TypeDirect peer
Description

Spanish-headquartered veterinary biologics and pharmaceuticals company specializing in animal vaccines (especially poultry and swine) with global presence. Most direct comparable on geography, species focus, and biological manufacturing scale to Calier.

TypeDirect peer
Description

US-listed animal health and nutrition company focused on livestock (poultry, swine, cattle) vaccines, medicated feed additives, and minerals. Comparable on production-animal emphasis and biologicals manufacturing, particularly in poultry.

TypeDirect peer
Description

French-based global animal health player focused on vaccines, pharmaceuticals, and companion animal products with significant poultry vaccine franchise. Comparable on species mix, biologicals emphasis, and private ownership structure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries12 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Calier

Veterinary Pharmaceuticalscalier.com

Calier is a Barcelona-based veterinary pharmaceuticals and biologicals manufacturer, founded 1968, producing 250+ vaccines, antiparasitics, anti-inflammatories, and nutritional supplements for companion animals, poultry, swine, ruminants, and beekeeping across 80+ countries through 12 subsidiaries.

What Calier does

Calier (legal entity Laboratorios Calier S.A.) is a Barcelona-headquartered veterinary pharmaceuticals and biologicals manufacturer founded in 1968 and operating as a subsidiary of the Spanish diversified group Grupo Indukern. The company develops, manufactures, and markets more than 250 products spanning five species verticals: companion animals (dogs, cats, horses, ornamental birds), poultry, swine, ruminants, and beekeeping. Its product portfolio includes biological vaccines, antibiotics, anti-inflammatory drugs, antiparasitics, disinfectants, nutritional supplements, sedatives, and custom autovaccines. The flagship biological franchise centers on Salmonella control in poultry, anchored by Primun Salmonella E, a freeze-dried live attenuated Salmonella Enteritidis vaccine carrying unique antibiotic-resistance markers that enable DIVA differentiation from field strains, and the first live vaccine authorized for use during the laying period by European Medicines Agencies in May 2021. A complementary inactivated bivalent vaccine (Salmonelbac Hidrosa) supports a mixed live-plus-inactivated vaccination strategy.

The company operates four owned production plants in Spain (Les Franqueses del Vallès headquarters plus a biological plant in León), Colombia (Cali), Morocco (Salé), and Uruguay (Montevideo), and distributes through 12 wholly-owned subsidiaries plus third-party distributors to veterinary professionals, farms, and animal production facilities in more than 80 countries across Europe, Latin America, North America, and Africa. Go-to-market is enterprise field sales with species-specialized Technical Services teams advising on-farm solutions, supplemented by the CECADI diagnostic center (PCR-based water and tissue analysis) and the WEVAP digital platform launched in 2022 for auditing poultry vaccination programs via biosafety scoring, preparation checks, application monitoring, and post-vaccination evaluation. The company monetizes primarily through one-time product sales of vaccines and pharmaceuticals, with added-value services layered around technical advice, custom autovaccines, and digital diagnostics.

Revenue is not consolidated publicly; the disclosed Venezuela subsidiary reported 67M EUR in 2022 with 340+ employees, while global headcount figures are inconsistent across sources (firmographics estimate 101-250 globally versus Venezuela alone exceeding 340), suggesting Calier is a mid-tier multinational animal health player with no external venture capital or public market exposure, owned within the Indukern corporate group.

Calier firmographics

Firmographics
Name
Calier
Legal name
Laboratorios Calier S.A.
Website
https://calier.com
Company type
Private
Founded year
1968
Operating status
Operating
Headcount range
101–250 employees
Short description
Calier is a Barcelona-based veterinary pharmaceuticals and biologicals manufacturer, founded 1968, producing 250+ vaccines, antiparasitics, anti-inflammatories, and nutritional supplements for companion animals, poultry, swine, ruminants, and beekeeping across 80+ countries through 12 subsidiaries.
Ownership category
akta.pro rank

Calier industry classification

Industry
Product category
Veterinary Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071)
akta.pro primary industry
Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI)
akta.pro secondary industries
Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA)

Keywords

  • Veterinary pharmaceuticals
  • Animal biologicals
  • Livestock vaccines
  • Veterinary medicines
  • Animal health products

Where Calier is headquartered

Location

Headquarters

HQ city
Barcelona
HQ country
Spain
HQ region
Europe

Offices13 records

Markets served

Calier business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Veterinary Pharmaceutical Products: Sale of pharmacological and biological products including vaccines, antibiotics, anti-inflammatory drugs, antiparasitics, disinfectants, nutritional supplements, and sedatives for companion animals and production animals (poultry, swine, ruminants, bees).
  2. Biological Products: Manufacturing and sale of biological products including live and inactivated vaccines for avian salmonellosis and other animal diseases. Production plants in Spain, Colombia, Morocco, and Uruguay.
  3. Technical Services: Added-value services including technical advice, farm auditing tools (WEVAP), and specialized technical support by species to help professionals maximize farm performance.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Calier product offering

Product offering

Core offering

Laboratorios Calier S.A. is a veterinary pharmaceutical laboratory founded in 1968 in Barcelona, Spain, that develops, manufactures, and distributes pharmaceutical and biological products for animal health, including vaccines and medicinal specialties for livestock and companion animals. The company operates four production plants (in Spain, Colombia, Morocco, and Uruguay), supports 12 subsidiaries, and markets more than 250 products in over 80 countries.

Product overview

Calier (Laboratorios Calier S.A.) is a veterinary pharmaceuticals company with over 55 years of experience offering a portfolio of more than 250 products across five animal segments: companion animals, poultry, swine, ruminants, and beekeeping. The portfolio includes pharmacological and biological products such as vaccines (Primun Salmonella E, Primun Salmonella T, Salmonelbac Hidrosa, Fixr PRRS Inac), antiparasitics (Dynacan, Merlin), anti-inflammatories (Adocam), nutritional supplements (ComPet line), and autovaccines. Services include CECADI diagnostic center and WEVAP digital vaccination auditing tool. Products are marketed in over 80 countries through 12 subsidiaries with manufacturing plants in Spain, Colombia, Morocco, and Uruguay.

Differentiator

Problem solved

Functional benefit

Brands

  • Primun Salmonella E: Live attenuated Salmonella Enteritidis vaccine for poultry, first authorized for use during laying period
  • Primun Salmonella T
  • Dynacan
  • Merlin
  • Adocam
  • SalmonelBac Hidrosa
  • ComPet
  • CECADI
  • WEVAP

Products and services

  • Primun Salmonella E Salmonella vaccine for poultry, part of Calier's range of biological products aimed at preventing salmonellosis in livestock production.
  • WEVAP Veterinary pharmaceutical/biological product contributing to Calier's portfolio of more than 250 animal health products sold worldwide.

Quantifiable outcome

  • Primun Salmonella E demonstrated protection up to 95 weeks of life in layers
  • +4 more outcomes

Companies that use Calier

Customer profile

Segments6 records

Ideal customer profiles2 records

Calier technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Calier partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered minor and core.

  • Fundación Amigos de las Abejas (Friends of Bees Foundation)minorOthersCharitable partnership as part of the 'Zumbados por las Abejas' project. Calier donates 3€ per photograph received in their Beekeeping Photo Contest to support awareness programs about pollinating insects and ecosystem conservation.
  • Sierras AndaluzasminorStrategic or Co-development PartnerSector partnership for beekeeping awareness and promotion of technical knowledge and local honey consumption in Andalusia, Spain.
  • La TarragoninaminorStrategic or Co-development PartnerSector partnership for beekeeping sector promotion and technical knowledge sharing in the Tarragona region.
  • FunbrainminorStrategic or Co-development PartnerEducational content collaboration to create digital educational materials about bees and beekeeping for schools across Spain as part of the 'Zumbados por las Abejas' project.
  • Ambientech FoundationminorStrategic or Co-development PartnerCollaboration on educational materials and workshops in schools about the importance of beekeeping and ecosystem balance.
  • Microsoft 365minorOthersCloud-based productivity and collaboration tools provider located outside the EU but compliant with GDPR regulations.
  • SalesforceminorOthersCustomer relationship management platform provider located outside the EU but compliant with GDPR regulations.
  • External Sample Collection CompaniesminorImplementation/ SI/ Consulting PartnerPartnership with external companies specializing in sample collection and water quality testing in Spain to provide comprehensive WEVAP vaccination audit services.
  • INTA Argentina (Instituto Nacional de Tecnología Agropecuaria)coreStrategic or Co-development PartnerResearch partnership with INTA Argentina led by Dr. Pablo Chacana for conducting vaccine efficacy challenge trials using Salmonella Enteritidis strains, in coordination with SENASA (National Agricultural Health and Quality Department).

Scale indicators10 records

Recent moves6 records

Expansion highlights5 records

Calier competitors and assessment

Company assessment

Direct peers

  • Vetoquinol: Independent French veterinary pharmaceutical company with portfolio of pharmaceuticals, parasiticides, and nutrition products for companion and production animals. Similar size, private-listed mid-cap profile, and therapeutic overlap.
  • Dechra Pharmaceuticals: UK-based specialty veterinary pharmaceuticals company acquired by EQT, with strong portfolio in companion animal endocrinology, dermatology, and anti-infectives. Comparable on mid-cap specialty pharma positioning though more companion-animal weighted.
  • Virbac: Independent French animal health company offering vaccines, pharmaceuticals, and diagnostics across companion and production animals. Similar mid-cap profile, broad species portfolio, and direct overlap in antiparasitics and biologicals.
  • Hipra: Spanish-headquartered veterinary biologics and pharmaceuticals company specializing in animal vaccines (especially poultry and swine) with global presence. Most direct comparable on geography, species focus, and biological manufacturing scale to Calier.
  • Phibro Animal Health: US-listed animal health and nutrition company focused on livestock (poultry, swine, cattle) vaccines, medicated feed additives, and minerals. Comparable on production-animal emphasis and biologicals manufacturing, particularly in poultry.
  • Ceva Santé Animale: French-based global animal health player focused on vaccines, pharmaceuticals, and companion animal products with significant poultry vaccine franchise. Comparable on species mix, biologicals emphasis, and private ownership structure.

Broad incumbents

  • Elanco Animal Health: Large global animal health company spanning companion animal, livestock, and poultry therapeutics and vaccines. Broad incumbent competitor across all of Calier's species segments.
  • Boehringer Ingelheim Animal Health: Global animal health division of Boehringer Ingelheim, with major positions in poultry and swine vaccines including PRRS. Direct competitor in Calier's swine PRRS vaccine franchise (Fixr PRRS Inac).
  • Zoetis: World's largest pure-play animal health company with the broadest portfolio across species, therapeutics, vaccines, diagnostics, and digital. Represents the dominant incumbent Calier competes against across multiple species segments.

Emerging players

  • Innovacyn: US-based animal health company specializing in wound care, dermatology, and nutritional supplements for companion and production animals. Niche overlap in companion animal supplements (ComPet line category).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Calier social profiles

Digital presence

Calier financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Calier leadership team

Management profile

Number of profiles

Profiles1 record

Calier subsidiaries and ownership

Company hierarchy

Subsidiaries12 records

Calier funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Calier M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Calier

What does Calier do?

Laboratorios Calier S.A. is a veterinary pharmaceutical laboratory founded in 1968 in Barcelona, Spain, that develops, manufactures, and distributes pharmaceutical and biological products for animal health, including vaccines and medicinal specialties for livestock and companion animals. The company operates four production plants (in Spain, Colombia, Morocco, and Uruguay), supports 12 subsidiaries, and markets more than 250 products in over 80 countries.

Is Calier a public or private company?

Calier is a private company. It is classified as corporate owned and is currently operating.

When was Calier founded?

Calier was founded in 1968. It employs 101 to 250 people.

Where is Calier based?

Calier is headquartered in Barcelona, Spain, in the Europe region.

How does Calier make money?

Three revenue lines are on record. Veterinary Pharmaceutical Products are the primary driver. The others are biological Products and technical Services.

Who are Calier's main competitors?

Direct peers on record are Vetoquinol, Dechra Pharmaceuticals, Virbac, Hipra, Phibro Animal Health and Ceva Santé Animale. Broad incumbents are Elanco Animal Health, Boehringer Ingelheim Animal Health and Zoetis. Innovacyn is listed as an emerging player.

Does Calier have an API?

No public API is recorded for Calier.

What industry is Calier in?

Calier's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAKAI, Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO), with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals